top of page
National Pharmaceutical Congress II
November 28, 2007
The National Pharmaceutical Congress of 2007 was divided into three rapid-fire sessions entitled The Operating Climate, The Patient/Physician Climate, and The Innovation/Creativity Climate. These sessions provided the opportunity for leaders in the life sciences industry to present reflections, ideas and innovations.
Rapid Fire Session I: The Operating Climate
The Pangaea Group of Companies
Canada's Research-Based Pharmaceutical Companies (Rx&D)
The JBL Group
Solvay Pharma Inc.
P&G Pharmaceuticals Canada
Oxford Debate I
Moderator: Dr. Shafiq Qaadri, MPP,
Parliamentary Assistant to the Minister of Health Promotion
For the affirmative: Dr. David R. Greenberg, D. Dave HealthCare Solutions
For the negative: Marc Lalande,
Council for Continuing Pharmaceutical Education (CCPE)
Resolved: This house believes the role of the professional pharmaceutical representatives is outmoded and recommends an industry-wide reduction of drug reps by 20 percent
Nutritional Break, Networking
Rapid Fire Session II: The Patient/Physician Climate
IMS Health Canada
Novo Nordisk Canada Inc.
Merck Research Laboratories
Pharmaceutical Advertising Advisory Board (PAAB)
Rapid Fire Session III: The Innovation/Creativity Climate
Paladin Labs Inc.
Lundbeck Canada Inc.
Stiefel Canada Inc.
Concluding Remarks and Summary
Canadian Healthcare Marketing Hall of Fame Reception
Canadian Healthcare Marketing Hall of Fame Gala Luncheon
bottom of page